The company said its shot generated an 8.7-fold increase in neutralizing antibodies in humans against BA.2.86, which is being tracked by th...

These include US approval for a drug combination for prostate cancer and a needed recommendation on the Abrysvo vaccine from the US Centers...

It will include a mix of newly-approved jabs adapted for the now dominant Omicron strain, and the original vaccines developed to fight the ...

The news comes after months of anxious waiting by parents desperate to vaccinate their babies, toddlers and preschoolers, especially as COV...

GSK said on Saturday that it had received three unsolicited offers from Unilever for GSK Consumer Healthcare, but they were all rejected as...

The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the N...

The US multinational pharmaceutical and biotechnology firm further announced that its experimental antiviral pill to treat COVID-19 can cut...

Boston-based pharmaceutical company Moderna announced a new supply agreement with Australia for 25 million doses of its COVID-19 vaccine. T...

Officials from around the world are keen for British authorities to give them as much information as possible about the two reported cases ...

The Nikkei share average fell 0.22% to 26,751.24, but posted its fifth consecutive weekly gain. In the previous session, the index settled ...

Republicans and Democrats in Congress remained unable to reach agreement on fresh relief for a pandemic-hit U.S. economy, although some inv...

Oil prices, a crucial factor for the region's economies, firmed as hopes that producer group OPEC and its allies will delay a planned incre...

As recently as Oct. 20, markets were pricing rate cuts of up to 25 basis points from leading central banks by next autumn as the resurgent ...

Shares of Pfizer hit an all-time high of Rs 5,875 after the company said that its vaccine data suggests the shots maybe 90 per cent effecti...

News on Monday that a vaccine from Pfizer and BioNTech was more than 90% effective sparked a surge in financial markets around the world, a...

Among the stocks that touched their 52-week highs were Pfizer and Deepak Nitrite.